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Abstract
The colonization and development of gut microbiota immediately after birth is highly variable
and depends on several factors, such as delivery mode and modality of feeding during the
first months of life. A cohort of 31 mother and neonate pairs, including 25 at-term caesarean
(CS) and 6 vaginally (V) delivered neonates (DNs), were included in this study and 121
meconium/faecal samples were collected at days 1 through 30 following birth. Operational
taxonomic units (OTUs) were assessed in 69 stool samples by phylogenetic microarray
HITChip and inter- and intra-individual distributions were established by inter-OTUs correla-
tion matrices and OTUs co-occurrence or co-exclusion networks. 1H-NMRmetabolites
were determined in 70 stool samples, PCA analysis was performed on 55 CS DNs samples,
and metabolome/OTUs co-correlations were assessed in 45 CS samples, providing an inte-
grated map of the early microbiota OTUs-metabolome. A microbiota “core” of OTUs was
identified that was independent of delivery mode and lactation stage, suggesting highly spe-
cialized communities that act as seminal colonizers of microbial networks. Correlations
among OTUs, metabolites, and OTUs-metabolites revealed metabolic profiles associated
with early microbial ecological dynamics, maturation of milk components, and host
physiology.
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Introduction
The microbial colonization from birth to adulthood of a healthy human gut is characterized by
a dynamic sequence of events that plays a critical role in promoting intestinal homeostasis and
stimulating normal immune system (IS) development and response. These functions provide
an array of beneficial advantages to the human host, including nutrient processing and metab-
olism, energy storage, and protection against pathogen colonization [1–9]. The gastrointestinal
(GI) microbiota is composed by autochthonous (i.e., indigenous) and allochthonous (i.e., tran-
sient) microbes [2]. Most pathogens are allochthonous microorganisms. However, some poten-
tial pathogens can be considered autochthonous and normally reside unperturbed within the
colonic host microbiota until the ecosystem is perturbed and homeostasis is disturbed. Abnor-
malities in gut microbiome composition and associated changes in IS tolerance have been
increasingly linked with early-onset childhood diseases [10]. Pioneering gut constituents and
their impact on metabolic pathways in early infancy may have both short- and long-term
health-related implications in humans [4,11–14]. However, while gut microbiota in neonates is
characterized by high inter-individual variability and uneven distribution of taxa throughout
this developmental stage [15–18], it remains unclear what role this variation has in the function
and the progression of the microbial community in the very early stages of life [18].
Several studies have shown that both differential exposure of neonates to maternal vaginal,
faecal, and skin microbiota due to delivery mode (i.e., vaginal or C-section) and modality of
feeding during the first months of life (i.e., breastfeeding and/or formula-feeding) accounts for
the richness, diversity, and composition of the gut microbial community [1,18–25]. However,
little is known regarding the bacterial composition of meconium through to faeces during the
first weeks of life [16,26,27]. Studies on meconium bacterial diversity, highlighting the succes-
sion of gut microbiota communities, could assist in developing strategies for selecting health-
promoting microbiota for preservation throughout the lifespan of the host [28,29]. These
microbial communities could be considered targets for therapeutic intervention in several
chronic childhood diseases [30–33].
Gut microbiota contributes to the host metabolism through numerous mechanisms, includ-
ing increased energy harvested from the diet, modulation of lipid metabolism, altered endo-
crine function, and increased inflammatory response [34,35]. Microbiota metabolic functions
are mainly based on the fermentation of available substrates that have escaped digestion in the
upper GI tract and flaking enterocytes [36]. In the early days of life, the major sources of carbo-
hydrates for infant gut microbiota are human milk oligosaccharides (HMOSs), endogenous
glycans (mucines), undigested monosaccharides and lactose, and, in the case of formula feed-
ing, prebiotics [37]. Complex carbohydrates are principally degraded by Bifidobacterium, Lac-
tobacillus, and Bacteroides (HMOSs and mucin degraders) into small sugars (e.g., lactose),
which are further metabolized by glycolytic microbes, including lactate producing bacteria
such as Streptococcus, Staphylococcus, Enterococcus, and Enterobacteria [38].
Thus, a major challenge in the understanding of host–microbiome metabolic interactions,
notably the role of gut microbiota in early life, is how it affects an individual’s health program-
ming. Metabolomics may play a pivotal role in understanding the mechanism of infant intesti-
nal development. Such approaches involve the identification and quantification of hundreds of
small metabolites from bodily fluids and tissues, providing functional insights into the complex
interactions between gut microbes and the host [39]. While several NMR-based metabolomic
studies on human adult stool have been performed to evaluate the influence of diet on gut
microbiota or the association of dysbiosis with intestinal inflammatory diseases [40–42], meta-
bolomic investigations into the meconium or stool from infants are quite limited [43,44].
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The goal of this pilot study was to investigate the chronological succession and network of
interactions of gut microbiota operational taxonomic units (OTUs). Correlation maps among
OTUs and between OTUs and related metabolites were also determined by identifying NMR-
based faecal metabolome profiles during gut microbiota evolution throughout the first thirty
days of life. Correlation maps between OTUs and metabolome components allowed us to
investigate early phyla-associated metabolic activities, shedding light onto the metabolome
framework during early intestinal microbial development.
Results and Discussion
Early gut microbiota profiles: punctiform and longitudinal phyla
distribution
The temporal evolution of faecal microbiota was determined in a series of 31 healthy newborns,
including 25 CS- and 6 V-delivered babies from which relevant metadata were collected
(Table 1; S1 and S2 Tables). A total of 130 genus-like groups were analysed over 1, 2, 3, 7, 15,
and 30 days following birth (Fig 1; Sheets A-C in S3 Table). The 130 genus-like groups were
categorized under 5 phyla, Verrucomicrobia, Proteobacteria, Firmicutes, Bacteroidetes, Actino-
bacteria, or an “others” phyla group, which included Cyanobacteria (uncultured Chroococ-
cales), Fusobacteria (Fusobacteria), and Spirochaetes (Brachyspira). For phyla with a relative
abundance no greater than 0.24% in each analysed sample, no further qualitative and quantita-
tive analyses were considered (Fig 1; Sheet B in S3 Table). Proteobacteria and Firmicutes were
the major phyla represented at all time points (Fig 1). The meconium samples appeared to con-
tain all of the major phyla present in stool during early life and consisted mostly of Proteobac-
teria and Firmicutes, followed by Actinobacteria, and to a lesser extent by Verrucomicrobia
and Bacteroidetes. The progression of microbiota patterns during the first colonization events
clearly resembled chaotic series [45]. However, the first colonization could be dependent on
pivotal bacterial populations encountered at birth, which conferred a microbiota fingerprint
during the first hours and days of life [46,47] (Fig 1). Indeed, detectable patterns included: i)
persistent low levels of Bacteroidetes in CS-delivered babies with postponed colonization after
the first days of life, as recently reported [24]; ii) high levels of Verrucomicrobia in CS-deliv-
ered babies in early days compared to later days; and iii) high levels of Bacteroidetes in V deliv-
ered babies (Fig 1). After grouping samples into two subsets, 1–3 days and 7–30 days,
nonparametric Kruskal-Wallis tests were used to identify statistically significant differences
among phyla for CS-delivered neonates at each time point (Fig 2). When the Shannon diversity
indexes, which were calculated at the probe level, for the hybridization patterns for the 130
probes were grouped by feeding, timing, delivery, and gender categories, the only statistically
significant difference was between CS and V at 1–3 days (630.16 ± 30.98 SD vs. 653.10 ± 21.46
SD, p<0.03).
Early gut microbiota profiles: strength and direction of correlations
among phyla of seminal colonizers
During the first phase of development (1–3 days following birth, phase “a”), CS-associated gut
microbiota was prevalently composed of Proteobacteria and Firmicutes. At birth, Proteobac-
teria (median 63.13) and Firmicutes (median 26.4) were significantly negatively correlated (r =
-0.816; p = 0.025). At day 2, the relative abundance of Proteobacteria decreased by nearly half
(median 34.1) while the proportion of Firmicutes more than doubled (median 62.3), maintain-
ing a negative correlation (r = -0.982; p = 0.0004). At day 3, the relative abundance of Proteo-
bacteria decreased by almost two-thirds (median 12.94), while Firmicutes increased again
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(median 69.73), and they remained negatively correlated (r = -0.95; p = 1.08E-09) (Fig 2A; S4
Table; Sheet A in S5 Table). Indeed, in a culture-based study, it was reported that Enterobacte-
ria (i.e., Proteobacteria) and Gram(+) cocci (i.e., Firmicutes) were identified as the first gut
microbiota colonizers in healthy infants, hence producing a reduced environment favourable
for the establishment of later occurring anaerobic bacteria (Bacteroides [Bacteroidetes], Bifido-
bacterium [Actinobacteria], and Clostridium [Firmicutes]) [22]. In our correlation analysis,
during the first phase (phase “a”), Bacteroidetes was positively correlated with Verrucomicro-
bia at day 1 (r = 0.821; p = 0.023), Actinobacteria at day 2 (r = 0.976; p = 0.0008), and Actino-
bacteria (r = 0.759; p = 0.0004) and Verrucomicrobia (r = 0.491; p = 0.044) at day 3 (Fig 2A; S4
Table; Sheet A in S5 Table).
Table 1. Mother-neonate clinical features and sample numbers and analysis types at each time point.
Clinical features
Gestational age (weeks) 39.00 (37.571–41.571)
Delivery modality
Vaginal (%) 6 (19.5%)
Cesarean section (%) 25 (80.6%)
Infant features
Infant gender (male:female) 20:11
Head circumference (cm) 35 (32–37.5)





Collected samples Analyzed by genomics Nr.
(%)
Analyzed by metabolomics Nr.
(%)
Analyzed by integrated omics Nr.
(%)
Time course sampling
Days Nr. (%) FM BM fM MM 9 (13.0%) 17 (24.3%) 7 (15.6)
Day 1 31
(25.2%)
31 0 0 0
Day 2 30
(24.4%)
30 0 0 0 8 (11.6%) 17 (24.3%) 7 (15.6)
Day 3 28
(22.8%)
28 0 0 0 23 (33.3%) 15 (21.4%) 13 (28.9)
Day 7 15
(12.2%)
0 13 1 1 11 (16.0%) 9 (12.9%) 6 (13.3)
Day 15 10 (8.1%) 0 8 1 1 9 (13.0%) 6 (8.6%) 6 (13.3)
Day 30 9 (7.3%) 0 5 2 2 9 (13.0%) 6 (8.6%) 6 (13.3)
Total 123 69 70 45
Feeding modality3
FM 89 (72.3%) 40 (58.0%) 47 (67.1%) 27 (60%)
BM 26 (21.1%) 22 (31.9%) 16 (22.9%) 14 (31.2%)
fM 4 (3.3%) 3 (4.3%) 5 (7.1%) 2 (4.4%)
MM 4 (3.3%) 4 (5.8%) 2 (2.9%) 2 (4.4%)
Total 123 69 70 45
Data are shown as median and interquartile range or percentage.
1BMI, body mass index
2APGAR, appearance, pulse, grimace, activity, respiration
3FM, first- milk. or colostrum; BM, breast-milk; fM, formula-milk; MM, mixed-milk, BM plus fM.
doi:10.1371/journal.pone.0137347.t001
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During the second phase (7–30 days following birth, phase “b”), the course of the micro-
biota composition changed. At day 7, the proportion of Proteobacteria increased again (median
30.40) and Firmicutes decreased proportionally (median 53.91), with the trend continuing at
days 15 and 30, when the amounts of Proteobacteria and Firmicutes were similar (median 34.2
vs. 38.93, respectively [r = -0.811, p = 0.008] at day 15; median 40.8 vs. 35.8, respectively [r =
-0.7883, p = 0.048] at day 30) (Fig 2B; S4 Table; Sheet A in S5 Table).
Starting from day 15, the proportion of Actinobacteria increased until day 30 (median 5.74
and 7.80, respectively). Actinobacteria were most likely of maternal origin, as inferred by the
significantly lower Bifidobacterium content in colostrum compared to transitional milk micro-
biota and, in general, lower exposure in CS- compared with V- delivery mode [48]. However,
during phase “b”, particularly at day 7, Bacteroidetes was significantly and positively correlated
with Firmicutes (r = 0.730; p = 0.017) and Verrucomicrobia (r = 0.822; p = 0.040), which is in
agreement with the delayed gut microbiota colonization by Bacteroidetes in CS-delivered
babies (Fig 2B; S4 Table; Sheet A in S5 Table) [24].
Based on visual inspection, OTUs associated with the two CS-delivered baby groups at 1–3
and 7–30 days following birth showed similar correlation patterns, although the positive inter-
actions increased from phase “a” to “b” while the negative interactions diminished (Fig 3, Pan-
els A-B; Sheets B-D in S5 Table). In particular, for the CS-delivered babies at 1–3 days, a
moderate positive correlation among Actinobacteria members was observed, with the excep-
tion of Bifidobacterium, which was significantly correlated (p<0.005) with only 4 OTUs (i.e.,
Clostridia, Clostridium difficile, Bacteroides vulgatus, Bacteroides uniformis). Actinobacteria
Fig 1. Composition at phylum level of the gut microbiota profiles of 31 infants enrolled in the study for 30 days following birth. At each time point,
the gut microbiota was characterized by HITChip-based phylogeny.
doi:10.1371/journal.pone.0137347.g001
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correlation patterns were generally maintained at 7–30 days (Fig 3, Panel A, Sheet B in S5
Table). During phase “a”, Bacteroidetes members displayed a high general positive correlation.
However, the entire group did not correlate or only barely correlated with Bacilli (Sheet B in
S5 Table). Interestingly, Bacteroidetes showed negative or no correlations with Proteobacteria
(p<0.005). During phase “b”, among Bacteroidetes OTUs, highly positive correlations were
maintained with a general increase in the number of correlations with Bacilli group (p<0.005).
Furthermore, positive correlations among Clostridium clusters increased throughout phase
“b”, while negative correlations with Proteobacteria groups were maintained (p<0.005). Dur-
ing both phases, Bacilli showed a low intra-group positive correlation, which increased over
the time course, and a higher correlation with other Firmicutes OTUs but a negative correla-
tion with Proteobacteria (p<0.005). Also, for Clostridium clusters, the correlation profile
remained constant over the time course. Proteobacteria was the most uncorrelated group, not
only with other phyla but also among its own group’s OTUs (Fig 3, Panel B; Sheet C in S5
Table).
Despite the small number of samples collected from V-delivered babies at 1–3 days (9 stool
samples, S1 Table), V-associated gut microbiota OTUs correlations were estimated. Upon
visual inspection, no or weak correlations were observed compared to CS-groups during phase
“a” (p<0.005) (Fig 3, Panel C; Sheet D in S5 Table). The Actinobacteria groups showed a high
intra-group correlation and a relatively high correlation with Bacilli and Clostridia clusters but
a weak correlation with Bacteroidetes (p<0.005). The Bacteroidetes group showed a high
intra-group correlation but a very low or no correlation with other groups (p<0.005). Firmi-
cutes showed high positive intra-group correlations with Actinobacteria and only few with Pro-
teobacteria (p<0.005). Proteobacteria showed no or weakly positive correlations with most
groups (p<0.005). For V-delivered babies, the low number of correlations at 1–3 days might be
explained by the "inhibition" model proposed by Connell (1977), which suggests that all species
resist invasions of competitors [49]. In fact, the first bacterial occupants, originating from the
pre-adapted and “ready-to-use” maternal vaginal and faecal microbiota inoculum, constitute
an already mature and stable niche, pre-empting the space and excluding or inhibiting new
pioneers until the former die or are damaged. Only then, later colonizers appear and can reach
maturity [50]. It is possible that maternal niches transmitted to the baby during V delivery
include already stable and resilient bacteria [50]. However, in CS-delivered neonates, “starter”
bacteria belong to different ecosystems such as skin or the external host environment [2].
Moreover, the remarkable increase of CS gut microbiota correlations during “phase b” (Fig 3,
Panel B; Sheet C in S5 Table) suggests two major colonization phases, possibly induced by the
passage to transitional or mature breast milk (BM) feeding from day 7 onwards. The first colo-
nizers, generally opportunistic species (i.e., Pseudomonas aeruginosa, Staphylococcus) are able
to occupy “empty” environments, triggering different mechanisms of subsequent species settle-
ment. During phase “a” the richness, diversity, and complexity of interactions among OTUs
are low but immediately tend to increase over time, indicating that the relatively simple and
scarce bacterial communities present in the first week can tolerate the incoming establishment
of new species or pre-existing pioneers at lower growth kinetics [27,51–54]. However, after
“setting” the new environment, colonization by new species can be facilitated, producing and
enhancing positive correlations [50]. In a few cases, pioneers inhibit further species until a
release of resources through negative correlations. During phase “b” the number of interactions
Fig 2. Pie chart representing phyla taxa median values for 30 days following birth. Statistically significant differences in relative abundance at each time
point are reported below each graph (Kruskal-Wallis). Phyla correlation heat maps.Correlation levels (represented as colored squares) among phyla were
calculated by Pearson’s test for all 6 time points. Only squares with a significance p<0.05 are shown. Blue squares represent a positive correlation and red
squares represent a negative correlation. Panel A and Panel B report analyses for 1–3 days (phase “a”) and 7–30 days (phase “b”), respectively.
doi:10.1371/journal.pone.0137347.g002
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Fig 3. Pearson’s correlation heat maps for the 130 genus-like groups from the HITChip microarray. Panels A, B, and C show the correlation levels
(represented by colored squares) among groups, which were calculated by Pearson’s test for all 3 groups (CS-delivered 1–3 days, CS-delivered 7–30 days,
and V1-3 delivered days). Only correlations with a significance p<0.05 are represented. The colored scale indicates the correlation values.
doi:10.1371/journal.pone.0137347.g003
Early Gut Microbiota in Perinatal Development
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among OTUs may increase proportionally with the higher intake of nutrients, linked not only
to BM composition but also to the increased volume of milk intake [55,56]. It has long been
known that the concentration of many nutrients, such as carbohydrates (i.e., lactose), lipids (i.
e., fats), and bioactive compounds (i.e., minerals, proteins, water-soluble vitamins), increases
from FM to BM, while growth factors, antimicrobial factors, IgA, and lymphocytes decline
[55].
Co-occurrence networks of OTUs
In order to study the co-occurrence networks of the relative abundance of OTUs, microbial
clusters were visualized for CS- and V-delivered babies at 1–3 days (Fig 4, Panels A, C) and
CS-delivered babies at 7–30 days (Fig 4, Panel B). The central portion of each panel shows the
gut microbiota “core”, represented by the network of OTUs with the highest clustering coeffi-
cient, a function related to the number of correlations that in most instances was positive. In
Panel A, within the 130 OTUs framework, 124 positive and 53 negative correlations were
found. In Panel B, 121 correlations were positive and 42 negative. In Panel C, 103 correlations
were positive and 13 negative, confirming a reduced number of interactions in V-delivered
compared to CS-delivered babies at days 1–3. One main cluster was present in CS-delivered
babies at both 1–3 and 7–30 days, composed of 55 and 62 OTUs, respectively, while two clus-
ters were identified in the V-delivered babies, composed of 33 (i.e., cluster A) and 13 OTUs (i.
e., Bacteroidetes cluster B) (Sheet E in S5 Table). In order to assess the uniqueness of OTUs
(single network-tailored structure) or, alternatively, commonness (network “core” structure),
co-occurrence clusters were interpreted with reference to presence/absence in the CS 1–3, CS
7–30, and V 1–3 groups. The following gut microbiota network structures were identified: i)
unique OTUs associated with the CS-delivered group at 1–3 days; ii) unique OTUs associated
with the CS-delivered group at 7–30 days; iii) unique OTUs associated with the V-delivered
group at 1–3 days; iv) OTUs shared by groups i and iii; v) OTUs shared by groups i and ii; vi)
OTUs shared by all groups (S1 Fig; Sheet F in S5 Table). The “core” structure (i.e., structure
vi) was composed of 30 stable microbiota (SM) OTUs belonging to: Actinobacteria (1), Bacter-
oidetes (4), Cyanobacteria (1), Firmicutes (19), Proteobacteria (4), and Spirochaetes (1) (Sheet
F in S5 Table). The identification of a defined core, independently associated with the delivery
mode and lactation stage, provides support for the Savage theory, which is based on the assem-
bly of gut microbiota as a “niche-driven process” that results in the establishment of a SM, fol-
lowed by variable microbiota (VM) [57].
In the Savage model, specific niches, which are characterized by nutrients, habitat, and evo-
lutionary competition, select the species and their abundance and distribution, driving the
diversity of gut microbiota. The SM members are ‘autochthonous’ and are always found in
individuals regardless external stimuli, which drives the onset of delivery mode- and feeding-
dependent specific niches, likely shaped by allochthonous microbes [58]. This theory may
explain some ecological features of gut microbiota, including progression in the early stages of
microbiota onset and the evolution of neutral and niche distributions of microbial inhabitants
(S1 Fig) [59–64].
NMRmetabolic profiling
Carr-Purcell-Meiboom-Gill (CPMG)-NMR spectra were obtained from 70 faecal samples
from 21 newborns collected at 1, 2, 3, 7, 15, 30 days after delivery (Table 1; S1 Table). Thirty
metabolites were identified and quantified and three remained unidentified, reported as U1,
U2, and U3 (S6 Table). NMR spectra were characterized by resonances associated with short-
chain fatty acids (SCFAs), choline and derived metabolites (i.e., dimethylamine,
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trimethylamine), alcohols, acetoin, amino acids (AAs) and derivatives (i.e., 3-hydroxyisovale-
rate), tricarboxylic acid cycle intermediates and products of energy metabolism (i.e., lactate,
succinate, creatinine), formate, and sugars (fucose) and N-acetyl derivatives, including those
originating from both diet (i.e., HMOSs containing N-acetylglucosamine residue) and gut
mucosa, all of which were derived from microbial saccharolytic and proteolitic fermentation
and gut mucin degradation [36] (S6 Table). It has previously been shown that HMOSs from
colostrum (cHMOSs) can modulate the signalling pathways of immature mucosa, associated
with IS, which hyper-reacts to newly colonizing unfamiliar bacteria [65].
Time-dependence of NMRmetabolic settlement. A comparison of the 1H-NMR spectral
profiles of samples collected at 1, 2, 3, 7, 15, and 30 days showed that samples collected within
the first 3 days of life had fewer metabolites compared to samples obtained at days 7, 15, and
30 (S2 Fig; S7 Table). This rise in metabolites (e.g., 1H-NMR profiles of newborn no. 18, S1
Table; S2 Fig) likely reflects the increasing transit of milk low molecular weight (LMW) com-
ponents from the small intestine to the colon and the progressive gain of gut microbial biomass
[66,67]. In particular, several physiological factors can explain these metabolic changes during
days 7 to 30, including: i) increased breast milk intake volume; ii) increased intake of nutrients
related to milk maturation; and iii) decreased small intestine assimilation of LMW nutrients,
related to the gut closure process [68]. Interestingly, in humans the gut closure process is com-
pleted between 3 and 7 days after delivery [68]. Our results show that the total level of metabo-
lites increases over time, reflecting higher gut microbiota metabolic activity, possibly related to
breast milk maturation and progressive intake.
Time- dependence of NMRmetabolic profiling. A PCA analysis was performed to evalu-
ate time-dependent changes in 55 metabolic profiles from 16 CS-delivered newborns. The first
two components explained 42% of the total variance (30% and 12% for PC1 and PC2, respec-
tively). The score plot showed a net separation along PC1 between faecal samples collected at 1,
2, and 3 days and 7, 15, and 30 days (Fig 5, Panel A). In particular, considering the scores at
high PC1 values, the samples from 1–2 days clustered along PC2 more so than day 3 samples
(Fig 5, S3 Fig). The loading plot showed that, along PC1, faecal samples at days 1, 2, and 3 had
higher levels of isoleucine, leucine, glutamate, aspartate, dimethylamine, isocaproic acid, propi-
onate, 2-hydroxy-3-methylbutyrate, isovalerate, U1, and U2 than those collected at 7, 15, and
30 days (Fig 5, Panel B; S7 Table). In contrast, samples from 3, 7, 15, and 30 days were charac-
terized by higher acetate levels compared to those collected within the first two days (S7
Table). Moreover, the majority of faecal samples at days 1 and 2 had higher N-acetyl-derivative
(NAc1 and NAc2) levels than those collected at days 3, 7, 15, and 30, while NAc3 remained
unchanged (S8 Table; Fig 5, Panel B). At day 1, NAc may originate from the N-acetylated gly-
coproteins of gut mucosa, while at day 2 NAc may be contributed by ingested milk compo-
nents, such as N-acetylglucosamine-containing oligosaccharides or glycoproteins [69]. NAc
and acetate can be found at days 1–30, suggesting a substrate/product relationship that changes
as a function of time and is dependent on changes in gut microbiota. The level of butyrate was
lower at day 1 than at day 3 (Fig 5, Panel B), remained steady until day 7, and then declined by
half between days 15 to 30, following the concentration of milk carbohydrates (S8 Table) [70].
The metabolite content in the first 3 days of life is characterized by high AAs and AA catab-
olites and low acetate levels, while at days 15 and 30 the levels are reversed, suggesting an
Fig 4. Graphical representation of OTUs co-occurrence networks. Panel A shows the OTUs co-occurrence network for CS-delivered babies at 1–3 days
following birth (see sheet B in S5 Table for details). Panel B shows OTUs co-occurrence network for CS-delivered babies at 7–30 days following birth (see
sheet C in S5 Table for details). Panel C shows OTUs co-occurrence network for V-delivered babies at 1–3 days following birth (see sheet D in S5 Table for
details). Red line indicates a positive correlation and a green line indicates a negative correlation. Pearson’s test was used to evaluate the correlation
amongst OTUs (statistical significance was assessed with p<0.01).
doi:10.1371/journal.pone.0137347.g004
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Fig 5. Principal Components Analysis (PCA) of metabolic profiles from 55 CS-delivered newborns. Samples were analysed over the 30 days following
birth. Panel A: PC score plot. Panel B: loading plot. The first two components explained 42% of the total variance.
doi:10.1371/journal.pone.0137347.g005
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inverse relationship between protein/AA and acetogenic metabolism (S8 Table). For instance,
2-hydroxy-3-methylbutyrate and isovalerate originate from branched chain AAs (BCFAs) [71]
and are generally present in low quantities compared to SCFAs in the large intestine and origi-
nate exclusively from protein breakdown, thus representing illustrative pathway markers [72].
Moreover, milk and endogenous luminal proteins are consumed by gut microbiota metabolism
and by exocrine pancreatic proteases activity, releasing peptides, oligopeptides, and AA [73].
In accordance with colon anatomy and physiology, putrefactive protein processes become
quantitatively more important in the distal bowel, where the luminal pH is nearer to the opti-
mal for protease activity [74]. AAs can be directly incorporated into bacterial cells as building
blocks of proteins or metabolized by the microbiota, producing a complex mixture of metabolic
end products including SCFAs, BCFAs, and H2S [75]. In contrast, microbial production of ace-
tate originates from carbohydrates, oligosaccharides, or AAs depending on environmental con-
ditions and microbiota species [76]. Acetate makes up around 60–75% of the total faecal
SCFAs being formed by many habiting colon bacteria, with approximately one-third coming
from reductive acetogenesis, the process through which acetate is produced from an electron
acceptor (i.e., CO2) and electron donors (e.g., H2, CO, formate, etc.) by anaerobic bacteria
(acetogens, methanogens, and acetate-producing bacteria such as Clostridium spp.) [77] via the
reductive acetyl-CoA, or Wood-Ljungdahl, pathway [76,78]. In this pathway, CO2 is reduced
to CO, which is then converted to acetyl-coenzyme A through CO dehydrogenase and acetyl-
CoA synthase. The former catalyzes the reduction of CO2 and the latter combines the resulting
CO with a methyl group to give acetyl-CoA [78,79].
The higher levels of AAs and their catabolites observed in the first 3 days after delivery com-
pared to days 7, 15, and 30 suggest a shift in colon microbial fermentation consistent with milk
composition changes during the lactation process. Indeed, it is well known that FM contains
higher levels of proteins and lower levels of lactose and fatty acids than BM [55,56].
Correlations between metabolite-metabolite and metabolite-OTUs
To investigate metabolic activities associated with OTUs during the first month of life, the rela-
tionships among metabolites and between metabolites and OTUs were evaluated by Spear-
man’s rank-order correlation on sample sets analysed by both by 1H-NMR and HITChip
microarray (S1 Table). In particular, the correlations between OTUs and metabolites were
focused on microbial metabolism associated with acetate and AAs and their degradation inter-
mediates (e.g., dimethylamine, and NAc1, NAc2). There were a significantly inverse correla-
tions between acetate and isoleucine, leucine, 2-hydroxy-3-methylbutyrate, isovalerate,
dimethylamine, glutamate, aspartate, propionate, NAc1, and NAc2 (Sheet A in S9 Table,).
Such inverse correlations, highlighted by PCA, reflect the metabolic changes observed at days
1–3 and 7–30.
Correlations between OTUs and acetate, AAs, NAc1, and NAc2 were also examined, with a
focus on OTUs that were positively correlated with AAs and their derivatives and inversely cor-
related with acetate. Among Actinobacteria OTUs, Propionibacterium was positively correlated
with leucine, isoleucine, isovalerate, propionate, glutamate, aspartate, and dimethylamine and
negatively correlated with acetate (Fig 6, Panel A). Similarly, among Proteobacteria, Burkhol-
deria was positively correlated with leucine, isoleucine, isovalerate, propionate, glutamate,
aspartate, dimethylamine, and malonate and negatively correlated with acetate. Other bacterial
OTUs were positively correlated with only AAs and their derivatives. In particular, Xanthomo-
nadaceae (Proteobacteria) and Staphylococcus (Firmicutes) were positively correlated with iso-
leucine, 2-hydroxy-3-methylbutyrate, isocaproate, isovalerate, and aspartate (Fig 6, Panel C;
Fig 7, Panel A). Other Proteobacteria, such as Enterobacter aerogenes, Leminorella, and
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Yersinia, were positively correlated with NAc1 and NAc2 and negatively correlated with buty-
rate (E. aerogenes only) or acetate (Leminorella only) (Fig 6, Panel C). Among Actinobacteria,
Bifidobacterium was negatively correlated with leucine, isoleucine, 2-hydroxy-3-methylbuty-
rate, isocaproate, and isovalerate as well as with glutamate, malonate, and dimethylamine (Fig
6, Panel A). Among Firmicutes, Clostridium OTUs were positively correlated with acetate lev-
els (Fig 7, panel A).
Conclusions
In conclusion, gut microbiota phylogenetic tracking in meconium/faecal samples collected in
the first 30 days of life from CS-delivered babies revealed a largely chaotic development, within
which Proteobacteria and Firmicutes were the main phyla represented. Low levels of Bacteroi-
detes and Verrucomicrobia were present during the first 30 days and Actinobacteria starting at
day 15. In the first 3 days of life, CS-associated gut microbiota was mostly composed of Proteo-
bacteria and Firmicutes, which were inversely correlated, confirming that the first colonizers in
infants create a reduced environment favourable for the establishment of further niches of
anaerobic bacteria occurring later in life. Between 7 and 30 days, the trend in microbiota com-
position started to invert and there was an increase in maternal-originating Actinobacteria
from days 15 to 30, when milk composition and intake increased availability of nutrients as
well as Bifidobacterium. The microbial correlation analysis highlighted that, during the first
colonization phase (1–3 days), the diversity and complexity of interactions among OTUs were
already “structured” in groups of positive and negative interaction niches. During the second
phase (7–30 days) interactions among OTUs increased considerably, likely the result of
increased milk nutrient intake favouring bacterial activities.
No or weak correlations were found in V-delivered babies, whose representative bacterial
group mainly consisted in Bacteroidetes, possibly due to the first maternal-driven bacterial
inhabitants slowing subsequent bacterial colonization by ecological exclusion or inhibition.
The identification of a defined core, independent from delivery mode and feeding stage, sup-
ports the “niche-driven process” model that results in the establishment of a stable community
assembly in gut microbiota (SM), the precursor of VM.
NMR–based metabolic profiling was used for the first time to investigate faecal metabolome
in at-term newborns soon after birth. This analysis highlighted seminal relationships between
faecal microbiota development and metabolic pathways. PCA results and correlations among
metabolites and OTUs suggest that the faecal metabolome is characterized by OTUs with
highly specialized metabolic functions are triggered by milk nutrient digestion, microbial colo-
nization, and host physiology. In the first two days the gut microbial biomass metabolism was
lower compared to subsequent days, as shown by 1H-NMR spectra. Metabolic profiles reveals
higher protein metabolism, with high levels of free AAs and BCFAs and low levels of acetate
and butyrate associated with high levels of some Proteobacteria families and low levels of Bifi-
dobacteria and Clostridiaceae. In contrast, high levels of acetogenic metabolism were observed
from days 3 to 30 and were correlated with increased levels of some Clostridium families,
which metabolize carbohydrates to acetate and SCFA.
Fig 6. Correlation heat-map between OTUs and faecal metabolites. Significant correlations (p<0.05) for Actinobacteria (Panel A), Bacteroidetes (Panel
B), Proteobacteria (Panel C). 2OH3MB: 2-hydroxy-3-methylbutyrate; Isocapr: Isocaproate; Isoval: Isovalerate; Ile: Isoleucine; Leu: Leucine; EtOH: Ethanol;
Fuc: Fucose; 3OH-Isoval: 3-hydroxyisovalerate; Lac: Lactate; Ala: Alanine; But: Butyrate; Ac: Acetate; N-Ac: N-Acetyl moiety; Glu: Glutamate; Suc:
Succinate; DMA: Dimethylamine; Asp: Aspartate; TMA: Trimethylamine; Cr: Creatine; MA: Malonate; Cho: choline; MeOH: Methanol; Tyr: Tyrosine; Phe:
Phenylalanine; For: Formate.
doi:10.1371/journal.pone.0137347.g006
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Finally, the integration of genomic and metabolomic pipelines has allowed us to suggest a
functional picture of metabolism by microbial OTUs, primed by transitional/mature milk tro-
phic pathways, during perinatal development (Fig 8).
Fig 7. Correlation heat-map between OTUs and faecal metabolites. Significant correlations (p<0.05) for Firmicutes (Panel A) and Verrucomicrobia
(Panel B). 2OH3MB: 2-hydroxy-3-methylbutyrate; Isocapr: Isocaproate; Isoval: Isovalerate; Ile: Isoleucine; Leu: Leucine; EtOH: Ethanol; Fuc: Fucose;
3OH-Isoval: 3-hydroxyisovalerate; Lac: Lactate; Ala: Alanine; But: Butyrate; Ac: Acetate; N-Ac: N-Acetyl moiety; Glu: Glutamate; Suc: Succinate; DMA:
Dimethylamine; Asp: Aspartate; TMA: Trimethylamine; Cr: Creatine; MA: Malonate; Cho: choline; MeOH: Methanol; Tyr: Tyrosine; Phe: Phenylalanine; For:
Formate.
doi:10.1371/journal.pone.0137347.g007
Fig 8. Model of microbial metabolism in perinatal babies under trophic pathways associated with transitional/mature milk. The integration of
genomic and metabolomic pipelines suggests a functional picture of microbial metabolism, primed by transitional/mature milk trophic pathways, during early
development.
doi:10.1371/journal.pone.0137347.g008
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Materials and Methods
Study design and enrollment of subjects
This study is part of the Italian Baby Trial (IBT), under a collaborative project between Wagen-
ingen University (Wageningen, The Netherlands) and Children’s Hospital and Research Insti-
tute OPBG (Rome, Italy). Mother and neonate pairs were recruited at the Department of
Obstetrics and Gynaecology, San Camillo Hospital (Rome, Italy). Thirty-one healthy mothers
and their caesarean (CS) or vaginally (V) delivered neonates were included in the study after
careful evaluation for exclusion criteria (e.g., pre-term delivery, newborn GI and immunologi-
cal disorders, antibiotic administration during pregnancy) (Table 1; S1 Table and S2 Table).
In the first study phase (1–3 days following birth), mother/newborn clinical data were col-
lected during hospitalization (e.g., gestational age, head circumference, BMI [body mass index],
APGAR scores [appearance, pulse, grimace, activity, respiration indexes]), while domicile
mother’s interviews were performed during the entire second study phase (7–30 days following
birth).
At fixed time-points (e.g., 1, 2, 3, 7, 15 and 30 days), data on baby feeding modality were
recorded from 121 nurses’ and mothers’ interviews. Newborn stools were collected during hos-
pitalization (days 1–3) and at home (days 7–30). Feeding information included: i) colostrum or
first milk (FM) at 1–3 days; ii) transitional and mature breast milk (BM) after 3 days; iii) for-
mula (fM) or mixed milk (MM, i.e., BM plus fM) at 7–30 days (Table 1; S1 Table).
Ethics statement
The study protocols were approved by the Ethics Committee of the San Camillo-Forlanini
Hospital (protocol 460/CE; 27/03/2012) and by the Institutional Review Board of the Bambino
Gesù Children’s Hospital (protocol 295 LB; 16/05/2012). Informed written consent was
obtained from all mothers-to-be on behalf of themselves and their neonates.
Stool collection and sample barcoding
Fresh neonatal faeces were collected from diapers with a sterile gauze inlay to prevent liquid
absorption and were transferred into a stool collection container (FL Medical, Italy) at 4°C.
Samples were stored at -80°C prior to DNA and metabolite extractions for HITChip and meta-
bolome analyses, respectively (S1 Table).
DNA extraction
Genomic DNA was extracted from faecal samples and subjected to extraction quality control
(QC) as described previously with slight modification [80]. Briefly, to overcome the tarry tex-
ture of meconium, 1- and 2-day stool samples were resuspended and homogenized in 1.5 ml
PBS. In order to guarantee the representativeness of bacterial DNA (i.e., Gram(-), Gram(+),
acid-alcohol-fast bacteria), the homogenate meconium and faecal samples were submitted to
mechanical and thermal lysis. After centrifugation at 52×g for 5 min, the supernatant was sub-
jected to NucliSens easyMAG automatic DNA extraction, according to the manufacturer’s
instructions (BioMerieux, France). Alternatively, for meconium samples, DNA was extracted
using the QIAamp DNA stool mini kit (Qiagen, Germany). Finally, DNA was eluted into
100 μl TE buffer, quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Scien-
tific, USA), and adjusted to a concentration of 10 ng/μl for use as a template for microarray
hybridization and analysis. Gut microbial taxa were analysed using the phylogenetic microar-
ray HITChip [81]. Phylogenetic microarrays were custom-synthesized by Agilent Technologies
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(Agilent Technologies, Palo Alto, CA) and hybridized with DNA samples that successfully
passed the QC for HITChip hybridization reproducibility [81,82], (Table 1, S1 Table).
HITChip microarray data extraction and analysis
Data were extracted from microarray images using the Agilent Feature Extraction software,
version 9.1 (http://www.agilent.com), and analysed in terms of normalization and hybridiza-
tion reproducibility as previously described for faecal samples from adults [81,83]. The inten-
sity value of each probe, associated with a specific microbial taxon [81], was normalized using
quantile normalization applied to the collective spatially normalized measurements of each
sample [82] (Table 1; Sheet A in S3 Table). In detail, samples were hybridized in duplicate
and a>0.95 Pearson correlation coefficient of the natural logarithm of spatially normalized
signals, excluding outlier spots [82], was considered indicative of satisfactory HITChip hybrid-
ization reproducibility. Robust probabilistic averaging (RPA) was used to calculate relative
abundance. The accuracy of each probe was determined and the less accurate probes were
weighted lower in the summarization [84]. HITChip microarray data, expressed as normalized
hybridization signals, are provided as part of the supporting information in Sheet A in S3
Table (A_ Original HITChip data), consistent with PLOS data policy.
Statistics and network analyses
Measures of hybridization data obtained from 130 HITChip genus-like groups were computed
as medians with interquartile ranges (IQR) for each time point (S4 Table) and the correspond-
ing 130 OTUs were grouped at phyla (Fig 1) and bacterial family levels (data not shown). Shan-
non diversity index (including richness and evenness) was calculated at the probe level in R,
and groups (feeding, timing groups, delivery, gender) were compared by Student’s T test.
Intra-group and inter-group correlations at each time point among phyla relative abundance
values were evaluated by Kruskal-Wallis tests (Fig 2). In all analyses, statistical significance was
defined as p<0.05. Correlation matrices were obtained by Pearson coefficient and plotted as
heat maps for each time point (Fig 1) and for CS1-3, CS7-30, and V1-3 data subsets (Fig 2;
Sheets B-D in S5 Table). Co-occurrence network analyses of relative OTUs abundance in V
and CS babies were focused on CS1-3, CS7-30, and V1-3 groups (Sheet E in S5 Table). Graphi-
cal representations of CS1-3, CS7-30, and V1-3 co-occurrence OTUs networks for values of
p<0.05 (Fig 4) were visualized with Cytoscape 2.8.2 version and the presence of main micro-
bial clusters was evaluated using an MCODE plug-in. Only clusters with the highest score and
clustering coefficient were calculated with the Network Analyzer plug-in of Cytoscape 2.8.2
(S1 Fig; Sheet F in S5 Table). Additional statistical analyses were performed with SPSS (ver-
sion 20, IBM Corporation, Armonk, NY, USA), GraphPad Prism (GraphPad Software, version
5.01), and R (version 3.0.3). V groups at 1 and 2 days were excluded from the statistical analy-
ses but summarized qualitatively.
NMR-based metabolomic analysis
Metabolite extraction for 1H-NMR analysis. A subset of faecal samples (Table 1, S1
Table) was suitable for metabolite extraction (weight>100 mg) and further analysed by
1H-NMR spectroscopy (Table 1 and S1 Table). Faecal water was obtained as previously
described with the following modifications [85,86]. Briefly, frozen faeces were weighed and
homogenized by vortexing into cold PBS/D2O (1.2 ml). After centrifugation at 10,000×g for 10
min at 4°C, supernatants were filtered through a cell strainer (40 μm pore size) and further cen-
trifuged. Aliquots of 500 μl supernatant (faecal water) were added to 500 μl of D2O containing
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2 mM trimethylsilyl-sodium-deuterated propionate (TSP) as an internal standard (IS), and
0.05% sodium azide. Samples were stored at -80°C until 1H-NMR analysis.
1H-NMR spectra acquisition
1H-NMR analysis was performed at 298 K using a Bruker Avance 400 spectrometer (Bruker
BioSpin, Germany) equipped with a magnet operating at 9.4 Tesla and at 400.13 MHz for 1H
frequency. The standard pre-saturation sequence used for this study, a Carr-Purcell-Meiboom-
Gill (CPMG) sequence, prevented the presence of signals from larger, slower moving molecules
(e.g., polypeptides or polysaccharides) and kept the narrow signals from low molecular weight
molecules. A set of preliminary experiments was carried out to avoid any unwanted T2 effect.
The relaxation delay was 6.55 s, during which a low-power selective pulse was applied for sol-
vent signal pre-saturation, and 128 scans of 64 K points each were collected, preceded by 4
dummy scans. CPMG sequence consisted of 256 spin-echo cycles with an echo time of 1.4 ms.
Spectral width was set to 5,995.02 Hz (15 ppm) for standard two-dimensional (2D)1H-1H cor-
relation spectroscopy (COSY), total correlation spectroscopy (TOCSY), and 1H-13C heteronuc-
lear single quantum correlation (HSQC). Heteronuclear Multiple Bond Correlation (HMBC)
was performed on selected samples (test samples) to allow or confirm the assignment of spe-
cific metabolite peaks (S6 Table). Signal assignment was achieved by the acquired standard 2D
experiments (COSY, TOCSY, HSQC, HMBC) and confirmed by comparison with the litera-
ture [87], the Human Metabolome Database [88] and an in-house database.
1H-NMR data processing and analysis
One-dimensional (1D) NMR spectra were processed and quantified using ACD Lab 1D NMR
Manager ver. 12.0 software (Advanced Chemistry Development, Inc., Canada), whereas 2D
NMR spectra were processed using Bruker TopSpin ver.3.1 (Bruker BioSpin, Germany). The
acquired NMR spectra were manually phased and baseline corrected. Proton spectra were ref-
erenced to the chemical shift of the TSP methyl resonance at δ 0.00. Quantification of metabo-
lites was achieved by comparing the integrals of their specific signals with the IS integral and
normalized for proton numbers. The concentrations were expressed as μmol/g wet weight of
faeces. To avoid possible dilution effects on the levels of faecal metabolites, for each individual
metabolite the level was normalized. This procedure allowed for investigation into the relation-
ship between levels of metabolites and OTUs.
Statistics and correlation analyses
Statistical analysis were carried out using a combination of Sigmaplot 12.0 (Systat Software
Inc.) and The UnscrublerX ver. 10.3 (CAMO Software, Oslo, Norway) for univariate and mul-
tivariate analyses. To evaluate changes over time, Principal Component Analysis (PCA) was
performed on normalized metabolite levels from faecal samples from CS-delivered infants rep-
resenting the entire set of time points (i.e., 1–3, 7, 15, 30 days) (Sheet A in S7 Table). Data
were auto-scaled before analysis [89]. Changes in each individual metabolite over time were
evaluated by Kruskal-Wallis test; Dunn’s method was used as a pairwise multiple comparison
procedure, and a value of p<0.05 was considered statistically significant. Spearman’s rank cor-
relation test was used to assess the relationships among metabolites (Sheet A in S8 Table).
Only correlations with a value of p<0.05 were considered significant (Sheet A in S8 Table;
Sheets A-E in S9 Table).
Finally, to assess the relationship among OTUs and metabolites, Spearman's rank correla-
tion test was applied to faecal samples simultaneously analysed by both microarray HITChip
and 1H-NMR spectroscopy (Table 1, S1 Table) by using OTUs and corresponding normalized
metabolite levels for each sample. Only correlations with a value of p<0.05 were considered
significant (Sheets A-E in S9 Table).
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Supporting Information
S1 Fig. Graphical representation of variable and stable structures of gut microbiota
highlighted in different subsets of babies, stratified for delivery, feeding, perinatal age.
Venn diagram represents the OTUs specifically associated with each gut microbiota type or
shared by multiple gut microbiota structures.
(TIF)
S2 Fig. Carr-Purcell-Meiboom-Gill (CPMG) 1H-NMR signal profiles of faecal water
obtained from newborn nr. 18 (sample test) at each time point. 1: 2-hydroxy-3-methylbuty-
rate; 2: butyrate; 3: leucine; 4: isoleucine; 5: propionate; 6: 1,2-propanediol; 7: ethanol; 8: α-and
b-fucose; 9: lactate; 10: acetoin; 11: alanine; 12: acetate; 13-N-acetyl moieties 1,2,3; 14: gluta-
mate; 15, pyruvate; 16: succinate; 17: aspartate; 18: creatinine; 19: choline; 20: tyrosine; 21: phe-
nylalanine; 22: formate.
(TIF)
S3 Fig. 3D-plot of the scores for the first 3 PCs. The majority of samples at days 1 and 2 are
separated from those collected at day 3 along PC2.
(TIF)
S1 Table. Succession scheme of stool collection and HITChip microarray-based and
1H-NMR analyses. Baby code, gender, delivery, time course in days, feeding modality, sample
ID, HITChip analysis, 1H-NMR analysis are reported for each subject.
(DOC)
S2 Table. Enrolment metadata. For each mother-baby pair, gender, delivery mode, sample
collection time course, feeding modality, gestational age, baby BMI, APGAR score, newborn
clinical data, home setting, and socio-economic status are reported.
(XLS)
S3 Table. HITChip hybridization profiles and taxonomic cataloguing of newborn gut
microbiota. Sheet A, Raw microarray HITChip values obtained from all samples; Sheet B and
C, values of phyla and family relative abundances over the six sampling time points calculated
for each newborn.
(XLS)
S4 Table. Relative abundance of prevalent phyla and bacterial families in faecal samples
obtained from 31 newborns.
(DOC)
S5 Table. Computation values of OTUs correlations and co-occurrence networks. Sheet A,
correlation matrix at phylum level; Sheets A-C, list of OTUs co-occurrence and grade of inter-
action for CS 1–3, CS 7–30, and V1-3 days, respectively; Sheet D, correlation clusters calculated
by MCODE; Sheet E-F, list of OTUs found in correlation networks grouped by their unique-
ness or commonness in the CS- and V-based groups. Pearson’s test was used to evaluate the
correlation among OTUs (statistical significance was assessed with p<0.05).
(XLS)
S6 Table. 1H-NMRmetabolite assignment. 1H-NMR assignment of 33 metabolites identified
and/or quantified in 70 faecal samples from 21 newborns (16 CS- and 5 V-delivered infants)
collected at 1–3, 7, 15, and 30 days after delivery.
(DOC)
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S7 Table. Relative levels of metabolites in 55 faecal samples from 16 CS-delivered infants
over 30 days following birth. Data are reported as medians and ranges from first and third
quartile and were analysed by Kruskal-Wallis tests. Significant differences in metabolite levels
(p<0.05) are reported between day 1 and 2 (a), 1 and 3 (b), 1 and 7 (c), 1 and 15 (d), 1 and 30
(e), 2 and 3 (f), 2 and 7 (g), 2 and 15 (h), 2 and 30 (i), 3 and 7 (j), 3 and 15 (k), 3 and 30 (l), 7
and 15 (m), 7 and 30 (n), and 15 and 30 (o).
(DOC)
S8 Table. Metabolite quantity matrix for CS-and V-delivered babies.Metabolites quantified
in the samples listed in the A column are reported as normalized quantities (concentration
of μmol/g of wet weight of faeces).
(XLS)
S9 Table. Spearman's rank correlation for metabolite-metabolite and phylum-metabolite.
Data are reported as Spearman's rank correlation coefficient and p-value for each metabolite-
metabolite and metabolite–OTU correlation.
(XLS)
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